EXPRESSION VECTOR ENCODING CORONAVIRUS-LIKE PARTICLE Russian patent published in 2010 - IPC C12N15/86 

Abstract RU 2383621 C2

FIELD: chemistry; biochemistry.

SUBSTANCE: invention relates to genetic engineering and virology. The expression vector for cloning Class I viral fusion protein gene contains Coronavirus M protein gene, Coronavirus E protein gene, IRES site, a first eukaryotic promoter linked to the M protein gene, Coronavirus Spike gene and MCS site and a second eukaryotic promoter linked to the Spike gene.

EFFECT: vector can be used as DNA vaccine candidate against virus infection diseases.

18 cl, 1 dwg, 4 ex

Similar patents RU2383621C2

Title Year Author Number
ARTIFICIAL ECTOS_SC2 GENE ENCODING AN ECTODOMAIN OF THE SARS-COV-2 CORONAVIRUS S GLYCOPROTEIN WITH A C-TERMINAL TRIMERIZATION DOMAIN, A RECOMBINANT PLASMID PSTEM-RVSV-ECTOS_SC2, WHICH PROVIDES EXPRESSION OF THE ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-ECTOS_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733834C1
ARTIFICIAL GENE CODING A BICISTRONIC STRUCTURE FORMED BY RECEPTOR-BINDING DOMAIN SEQUENCES OF THE GLYCOPROTEIN S OF THE SARS-COV-2 CORONAVIRUS, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733831C1
ARTIFICIAL GENE STBL_RBD_TRM_SC2, CODING A BICISTRONIC STRUCTURE FORMED BY THE SARS-COV-2 CORONAVIRUS GLYCOPROTEIN S RECEPTOR-BINDING DOMAIN SEQUENCES, TRANSMEMBRANE REGION, P2A-PEPTIDE AND GLYCOPROTEIN G VSV, RECOMBINANT PLASMID PSTEM-RVSV-STBL_RBD_TRM_SC2, PROVIDING EXPRESSION OF ARTIFICIAL GENE, AND A RECOMBINANT STRAIN OF VESICULAR STOMATITIS VIRUS RVSV-STBL_RBD_TRM_SC2, USED TO CREATE A VACCINE AGAINST SARS-COV-2 CORONAVIRUS 2020
  • Imatdinov Ilnaz Ramisovich
  • Bochkareva Mariya Dmitrievna
  • Prudnikova Elena Yurevna
  • Tishin Anton Evgenevich
  • Pyankov Oleg Viktorovich
  • Gavrilova Elena Vasilevna
  • Maksyutov Rinat Amirovich
RU2733832C1
METHOD FOR CREATING RECOMBINANT ENTEROCOCCUS L3-SARSN1 STRAIN BASED ON BIOLOGICALLY ACTIVE ENTEROCOCCUS FAECIUM L3 STRAIN 2022
  • Suvorov Aleksandr Nikolaevich
  • Gupalova Tatyana Vitalievna
  • Leonteva Galina Fedorovna
  • Bormotova Elena Alekseevna
  • Kramskaya Tatyana Anatolevna
  • Desheva Yuliya Andreevna
RU2820058C1
INTEGRATIVE PLASMID VECTOR pVEAL3-RBDdel, PROVIDING SYNTHESIS AND SECRETION OF RECOMBINANT PROTEIN OF RECEPTOR-BINDING DOMAIN RBDdelta OF CORONAVIRUS SARS-CoV-2 IN MAMMALIAN CELLS, RECOMBINANT CELL LINE STRAIN CHO-K1-RBDdelta AND RECOMBINANT PROTEIN RBDdelta SARS-CoV-2 PRODUCED BY CELL LINE STRAIN 2023
  • Nesmeyanova Valentina Sergeevna
  • Merkuleva Yuliya Aleksandrovna
  • Isaeva Anastasiya Aleksandrovna
  • Shcherbakov Dmitrij Nikolaevich
  • Volkova Natalya Vyacheslavovna
  • Belenkaya Svetlana Valerevna
  • Borgoyarkova Mariya Borisovna
  • Volosnikova Ekaterina Aleksandrovna
  • Esina Tatyana Igorevna
  • Zajkovskaya Anna Vladimirovna
  • Pyankov Oleg Viktorovich
  • Ilichev Aleksandr Alekseevich
RU2816175C1
PEPTIDE IMMUNOGENS AND VACCINE COMPOSITION AGAINST COVID-19 WITH THE USE OF PEPTIDE IMMUNOGENS 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2743593C1
PEPTIDE IMMUNOGENS USED AS COMPONENTS OF VACCINE COMPOSITION AGAINST COVID-19 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2743594C1
VACCINE COMPOSITION AGAINST COVID-19 2020
  • Ryzhikov Aleksandr Borisovich
  • Ryzhikov Evgenij Aleksandrovich
  • Bogryantseva Marina Polikarpovna
  • Gavrilova Elena Vasilevna
  • Danilenko Elena Dmitrievna
  • Imatdinov Ilnaz Ramisovich
  • Maksyutov Rinat Amirovich
  • Nechaeva Elena Avgustovna
  • Popova Anna Yurevna
  • Pyankov Oleg Viktorovich
  • Pyankova Olga Grigorevna
  • Susloparov Ivan Mikhajlovich
RU2743595C1
PRODUCTION OF VIRUS-LIKE PARTICLES IN PLANTS 2011
  • D'Au Mark-Andre
  • Kutyur Manon
  • Lavua Per-Olive
  • Vezina Lui-Filipp
RU2655431C2
DNA VACCINE AGAINST SARS-COV-2 VIRUS BASED ON GENE THERAPY DNA VECTOR GDTT1.8NAS12, METHOD FOR ITS PREPARATION, STRAINS CARRYING GENE-THERAPY DNA VECTORS, METHOD FOR THEIR PREPARATION, METHOD FOR PRODUCTION ON INDUSTRIAL SCALE OF GENE-THERAPY DNA VECTORS 2020
  • Gamolski Anton
RU2759227C2

RU 2 383 621 C2

Authors

Vu Ljuehn'

Dates

2010-03-10Published

2004-11-26Filed